Mannose-Binding Lectin Genotype and Phenotype in Patients With Type 2 Diabetes and Myocardial Infarction: A report from the DIGAMI 2 trial

OBJECTIVE: The present study characterizes mannose-binding lectin (MBL), an activator of the complement system and thereby important for inflammatory activation, in patients with diabetes and myocardial infarction. RESEARCH DESIGN AND METHODS: Serum (S)-MBL was determined at hospital admission in 38...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Mellbin, L.G., Hamsten, A., Malmberg, K., Steffensen, R., Rydén, L., Öhrvik, J., Hansen, T.K.
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2010
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2963511/
https://ncbi.nlm.nih.gov/pubmed/20693349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc10-0903
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars